Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52  mg LNG-IUS: a non-inferiority randomised clinical trial.

CONCLUSION: Both progestin-only contraceptives significantly reduced two out of the three biomarkers evaluated. These two biomarkers could, therefore, be used as surrogate markers to follow up medical treatment of endometriosis-associated pain. PMID: 30372645 [PubMed - as supplied by publisher]
Source: The European Journal of Contraception and Reproductive Health Care - Category: Reproduction Medicine Authors: Tags: Eur J Contracept Reprod Health Care Source Type: research